Home › Funds › Siren, L.L.C. › TNGX

Siren, L.L.C. position in TNGX

Tango Therapeutics, Inc. · Health Care

Siren, L.L.C. reported holding 6,784,081 shares of TNGX (Tango Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$169.3M, representing 4.02% of its reported portfolio and ranking #6 among its reported holdings. Siren, L.L.C. has disclosed TNGX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)6.78M sh
Reported value held$169.26M
Portfolio Weight4.02%
First reportedQ3 2024
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s TNGX position evolved

Siren, L.L.C. first disclosed a stake in TNGX in Q3 2024 at 2,603,897 shares (US$20.1M). The position peaked in Q2 2026 at 6,179,364 shares, worth US$193.2M. Across 9 filings, Siren, L.L.C. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 6,784,081 shares valued at US$169.3M — an increase of 604,717 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2025 (shares rose 64% over the following quarter), a 75% increase in Q3 2025 (shares rose 5% over the following quarter), a 39% increase in Q4 2025 (shares rose 136% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.60M $20.05M New
Q4 2024 2.60M $8.05M Hold
Q1 2025 2.57M $3.51M Reduce
Q2 2025 3.36M $17.23M Add
Q3 2025 5.88M $49.42M Add
Q4 2025 8.17M $72.35M Add
Q1 2026 5.66M $118.35M Reduce
Q2 2026 6.18M $193.17M Add
Q3 2026 6.78M $169.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (Tango Therapeutics, Inc.) is a Health Care company. 84 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has Siren, L.L.C. held TNGX?

Siren, L.L.C. has disclosed TNGX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in TNGX?

As of Q3 2026, Siren, L.L.C. holds 6.78M shares of TNGX (Tango Therapeutics, Inc.), valued at $169.26M, representing 4.02% of its reported portfolio and ranking #6.

Has Siren, L.L.C. been buying or selling TNGX?

In the latest 13F filing (Q3 2026), Siren, L.L.C. increased its position in TNGX. The position peaked in Q2 2026 at 6.18M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 84 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.